MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 246 filers reported holding MIRATI THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 1.06 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $7,013 | +20.6% | 161 | 0.0% | 0.00% | – |
Q2 2023 | $5,817 | -15.9% | 161 | -13.4% | 0.00% | – |
Q1 2023 | $6,915 | -18.0% | 186 | 0.0% | 0.00% | – |
Q4 2022 | $8,428 | -43.8% | 186 | -15.1% | 0.00% | -100.0% |
Q3 2022 | $15,000 | 0.0% | 219 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $15,000 | -16.7% | 219 | +1.9% | 0.00% | 0.0% |
Q1 2022 | $18,000 | -43.8% | 215 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $32,000 | +6.7% | 215 | +25.0% | 0.00% | -50.0% |
Q3 2021 | $30,000 | +11.1% | 172 | +2.4% | 0.00% | +100.0% |
Q2 2021 | $27,000 | – | 168 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |